The study spans multiple centers across the U.S., and will assess Aurora Spine’s Zip interspinous fixation device in patients with symptomatic degenerative disc disease. Neurosurgeons, orthopedic surgeons and interventional pain physicians are all collaborating for the research.
“This study represents a leap forward in how we understand and treat lumbar spinal conditions,” Steven Falowski, MD, co-principal investigator, said in the release. “The data we’ve gathered is critical, it’s not just numbers, it’s the foundation for improving patient lives. The Refine study will provide the highest level of scientific evidence to guide clinical decision-making and elevate the standard of care.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
